RecruitingPhase 2NCT06629259

Guanfacine for Alcohol Use Disorder (AUD)

Guanfacine for Alcohol Use Disorder (AUD): a Telehealth Approach

Sponsor

Indiana University

Enrollment

200 participants

Start Date

Oct 3, 2025

Study Type

INTERVENTIONAL

Conditions

Alcohol Use Disorder

Summary

The investigators assess whether guanfacine extended release (GXR; 3mg/d) compared with placebo (PBO) will attenuate drinking and drinking-related factors in N=200 men and women with Alcohol Use Disorder (AUD) across 12-weeks.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Guanfacine Extended Release (XR) and a drug called Placebo for people with alcohol use disorder. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.